Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC receives funding to advance cattle vaccines
The funding will support studies into bovine babesiosis and bovine tuberculosis vaccines to enhance cattle welfare.

The grants will support research into bovine babesiosis and bovine tuberculosis vaccines. 

Two international 'pump-prime' grants amounting to almost £168,000 have been awarded to the Royal Veterinary College (RVC) to advance research into cattle vaccines.

The funding from the International Veterinary Vaccinology Network (IVVN) will support studies into bovine babesiosis and bovine tuberculosis vaccines to enhance cattle welfare.

The first grant, amounting to £89,000, will support the investigation of the genetic diversity and vaccine potential of thrombospondin-repeat domain (TSR) proteins against bovine babesiosis.

The second grant, totalling nearly £79k, will use Nanopore DNA sequencing to improve understanding of genetic diversity in bovine tuberculosis (bTB) strains circulating in Algeria.

Vaccinology lecturer Dr Ellen Knuepfer will lead the research into TSR alongside Dr Silvina Wilkowsky, an independent researcher based at the Institute of Agricultural Biotechnology and Molecular Biology, Argentina.

She said: “This funding will allow us to test a group of proteins called TSR proteins not only on a genetic level, but also explore their function, and application as vaccine antigen to protect cattle from this often fatal disease.”

Dr Sharon Kendall, associate professor in molecular bacteriology and Dr Dong Xia, senior lecturer in bioinformatics at the RVC will be leading the research into bovine tuberculosis.

They will work alongside Dr Rachel Tanner, associate professor of One Health at the University of Oxford and Dr Mammar Khames, researcher and lecturer at the University of Medea, Algeria. 

Dr Tanner said: “This is an excellent opportunity to further strengthen links between Oxford and RVC, as well as form a new partnership with researchers at Medea University. The project brings together a broad range of expertise to create a team that is greater than the sum of its parts, tackling the important global One Health issue of bovine TB.”

Dr Khames added: “As a veterinarian and zoonotic disease researcher in Medea University, Algeria, I'm delighted to be working with collaborators from the RVC and Oxford University on this project, which will enable me to acquire skills in the field of bovine tuberculosis research. Let's hope this will lead to promising results and a wider project in the future.”

Image (C) RVC.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.